RN Mobile Menu

Search form


American College of Rheumatology (ACR) 2015 annual meeting

2015 ACR/ARHP Meeting Coverage from San Francisco

The University of Colorado’s Sterling West, MD, opened the American College of Rheumatology's annual meeting on Sunday with a review of cost-effective strategies in RA patient care and promising new therapies. Click here for news from this year’s meeting.    (©StevenGregoryPhotography)

American College of Rheumatology (ACR) 2015 annual meeting


A Phase II trial of a new monoclonal antibody drug shows promise for a potential new treatment for lupus.


Rheumatologists and staff should communicate about coding, says ACR’s Melesia Tillman who offers an ICD-10 recap post ACR/ARHP 2015.

Men and women with incident bone fractures face increased mortality by two, but even higher for those with proximal fractures.


Women can reduce their risk of developing rheumatoid arthritis by eating a healthy diet, study presented at 2015 ACR/ARHP shows.

Achieving sustained remission in early rheumatoid arthritis is less likely for overweight and obese patients as compared to thinner counterparts.

Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.

IL-6 inhibitors sarilumab, an investigational drug, and tocilizumab, an established treatment in RA, are equally safe, shows two studies presented at ACR/ARHP 2015.


Subscribe to American College of Rheumatology (ACR) 2015 annual meeting on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.